611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Health Sciences
Resources
Basic InformationLatest News
Type 2 Diabetes May Be Bad for Brain Health'Brain Age' May Help Predict When You'll DieParkinson's Disease May Originate in Gut, Study SaysBlood-Based Genome Testing Feasible for Rapid Mutation AssayBlood Test May Gauge Death Risk After Surgery150-Year-Old Drug May Shorten 'Off' Time for Parkinson's PatientsBrain May Be Organized by Functions, Not Body PartsBody Temperature Might Give Clues to ComaCould Young Blood Boost the Aging Brain?A 'Brainwave' to Help Fight PTSDDizziness in Parkinson's May Be Due to Cerebral HypoperfusionMisunderstood Gene Tests May Lead to Unnecessary MastectomiesScientists Extend Lives of Mice With ALSFDA Approves 1st Direct-to-Consumer Genetic Risk TestsFDA OKs 1st At-Home Genetic Tests for 10 Disorders'SuperAgers' Have Less Whole-Brain Cortical Volume LossHigh Thyroid Hormone Levels Tied to Stiffer ArteriesBrain Changes May Mark Risk of Financial Exploitation in SeniorsRegular Exercise Slows Decline Even in Advanced Parkinson's DzBrain-Computer Link Restores Some Movement to Quadraplegic ManScientists Spot Gene for Rare Disorder Causing Deafness, BlindnessNew Technology Makes Gene Mapping Cheaper, Faster: StudyTurning Back the Aging Clock -- in MiceNew Parkinson's Drug Xadago ApprovedBrain 'Rewires' to Work Around Early-Life BlindnessBrain Training for Cancer Survivors' Nerve DamageASA: Vagus Nerve Stimulation May Enhance Stroke RecoveryGene Therapy: A Breakthrough for Sickle Cell Anemia?Gene Therapy Shows Promise for Aggressive LymphomaThe Brain Can Produce Its Own Sugar: ReportCould Parkinson's Disease Raise Stroke Risk?NHL Veterans Pledge Their Brains to ResearchMRIs Can Be Safe for People With Heart Devices …Scientists Shed Light on Possible Cause of NearsightednessBrain Chip Helps Paralyzed 'Type' With Their MindDoes Mercury in Fish Play a Role in ALS?Repeat Head Hits May Not Put NFL Players at Risk of Motor ProblemsMRI Can Identify Early Signs of ASD in High-Risk InfantsEvidence of CTE Identified in Former Soccer PlayersSpace Reshapes Astronauts' Brains: StudyDiagnostic Potential for Blood-Based NfL in Parkinson's DiseaseIs It Parkinson's or Something Else? Blood Test Might Tell30 Former NFL Players Pledge Their Brains for ResearchAstronaut Twins Give Clues to Health Hazards of SpaceflightBrain-Computer Interface Lets Locked-In Patients CommunicateGene Discoveries Offer New Height InsightsBrain Scans Let 'Locked-In' ALS Patients CommunicateCaffeine Found to Reduce Age-Related InflammationfMRI May Be Better Way to Map Brain Prior to Epilepsy SurgeryVagus Nerve Might Play a Role in Fighting Inflammatory Disease
Questions and AnswersLinksBook Reviews
Related Topics

Medical Disorders
Mental Disorders
Mental Health Professions

Scientists Extend Lives of Mice With ALS

HealthDay News
by -- Robert Preidt
Updated: Apr 12th 2017

new article illustration

WEDNESDAY, April 12, 2017 (HealthDay News) -- A recent discovery in mice might one day lead to a new approach for treating people with amyotrophic lateral sclerosis (ALS), researchers report.

They found that suppressing a single protein significantly extended the lives of mice with a form of ALS, a progressive neurodegenerative condition also known as Lou Gehrig's disease.

In one experiment, untreated mice lived no longer than 29 days. Yet, some of the mice with a suppressed ataxin 2 protein were alive for more than 400 days, the study showed.

While these findings appear promising, they need to be viewed cautiously. What works in animals often doesn't pan out in humans.

In ALS, nerve cells in the brain and spinal cord degenerate. This leads to wasting of the muscles and the gradual loss of the ability to move, speak, eat or breathe. In most cases, paralysis and death occurs within two to five years, the researchers said.

Along with risk factors such as old age, mutations in certain genes can cause ALS. One indicator of ALS is clumps of a protein called TDP-43 in the brain. Previous research has shown a link between TDP-43 and ataxin 2, the study authors noted.

Cells need TDP-43 to survive, which means that that particular protein can't be completely suppressed. But ataxin 2 isn't necessary for cell survival, the researchers explained.

"We wanted to find out if we could protect these mice from the consequences of TDP-43 by lowering the amount of ataxin 2," study senior author Aaron Gitler, an associate professor of genetics at Stanford University, said in a school news release.

The researchers genetically engineered mice with ALS that were not yet showing symptoms to have either half the normal amount of ataxin 2 or to completely lack the protein. Compared to normal mice with ALS, those with half the ataxin 2 survived much longer.

"But what was really astounding was that when we completely removed ataxin 2, there was really an unprecedented survival; some of the mice lived hundreds and hundreds of days," said study author Lindsay Becker, a graduate student at Stanford.

Because TDP-43 clumping occurs in nearly all ALS patients, targeting ataxin 2 could be a widely effective treatment approach, Becker said.

The study was published online April 12 in the journal Nature.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more on ALS.